Preliminary report on effects of oxcarbazepine-treatment on serum lipid levels in children

European Journal of Neurology

Volumn 13, Issue 12, 2006, Pages 1389-1391

  Franzoni, E ^a,b   Marchiani, V ^a   Cecconi, I ^a   Moscano, F C ^a   Gualandi, S ^a   Garone, C ^a   Sarajlija, J ^a   Malaspina, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE   (Italy)

Author keywords

Children; High density lipoprotein cholesterol; Oxcarbazepine; Total cholesterol; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; OXCARBAZEPINE; TRIACYLGLYCEROL;

ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; EPILEPSY; FEMALE; HUMAN; LABORATORY TEST; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MEDICAL ASSESSMENT; MONOTHERAPY; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; MALE; TRIGLYCERIDES;

EID: 33750963273     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01535.x     Document Type: Article

References (14)

1. Calandre EP, Rodriguez-Lopez C, Blazquez A, Cano D. Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurologica Scandinavica 1991; 83: 250-253.
2. Berlit P, Krause KH, Heuk CC, Schellenberg B. Serum lipids and anticonvulsants. Acta Neurologica Scandinavica 1982; 66: 328-334.
3. Eiris JM, Lojo S, DelRio MC, et al. Effect of long-term treatment with antiepileptic drugs on serum lipids levels in children with epilepsy. Neurology 1995;45:1155-1157.
4. Verrotti A, Basciani FRD, Domizio S, Sabatino G, Morgese G, Chiarelli F. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatric Neurology 1998; 19: 364-367.
5. Franzoni E, Govoni M, D'addato S, et al. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs. Epilepsia 1992;33:932-935.
6. Bramswig S, Sudhop T, Luers C, von Bergmann K, Berthold H.K. Lipoprotein(a) concentration increases during treatment with carabamazepine. Epilepsia 2003;44:457-460.
7. Pylvanen V, Knip M, Pakarinen AJ, et al. Fasting serum insulin and lipid levels in men with epilepsy. Neurology 2003;60:571-574.
8. American Academy of Pediatrics. Committee on Nutrition. Statement on cholesterol. Pediatrics 1992;90:469-473.
9. Mahmoudian T, Iranpour R, Messri N. Serum lipid levels during carbamazepine therapy in epileptic children. Epilepsy and Behavior 2005;6:257-259.
10. Isojarvi JI, Pakarinen AJ, Rautio A, Pelkonen O, Myllyla VV. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994;35:1217-1220.
11. Schachter S.C. Oxcarbazepine: current status and clinical applications. Expert Opinion on Investigational Drugs 1999;8:1103-1112.
12. Papacostas S. Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities. Journal of Child Neurology 2000; 15: 138-140.
13. Gillman MW, Cupples LA, Moore LL, Ellison RC. Impact of within-person variability on identifying children with hypercholesterolemia: Frammingham Children's Study. Journal of Pediatrics 1992; 121: 342-347.
14. Gidding SS, Dennison BA, Birch LL, Daniels SR, Gilman MW, Lichtenstein AH, et al. American Heart Association; American Academy of Pediatrics. Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation 2005; 112: 2061-2075.